Literature DB >> 17942022

The association of specific neuropsychological deficits with capacity to consent to research or treatment.

Barton W Palmer1, Gauri N Savla.   

Abstract

Informed consent is key to ethical clinical research and treatment, but partially rests on the ability of individual patients or research participants to use disclosed information to make a meaningful choice. Although the construct of decisional capacity emerged from legal and philosophical traditions, several investigators have begun examining the relationship of specific neuropsychological abilities to decisional capacity. This line of research may foster development of better consent procedures, as well as aid in refining the construct of decisional capacity toward a form that better reflects the underlying neurocognitive processes. We conducted a systematic search of the published literature and thereby identified and reviewed 16 published reports of empirical studies that examined the relationship between specific neuropsychological abilities and capacity to consent to research or treatment. Significant relationships between neuropsychological scores and decisional capacity were present across all the reviewed studies. The degree to which specific neuropsychological abilities have particular relevance to decisional capacity remains uncertain, but the existing studies provide a solid basis for a priori hypotheses for future investigations. These ongoing efforts represent an important conceptual and empirical bridge between bioethical, legal, and neuropsychological approaches to understanding meaningful decision-making processes.

Entities:  

Mesh:

Year:  2007        PMID: 17942022     DOI: 10.1017/S1355617707071299

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  27 in total

1.  Decisional capacity and consent for schizophrenia research.

Authors:  Allison R Kaup; Laura B Dunn; Elyn R Saks; Dilip V Jeste; Barton W Palmer
Journal:  IRB       Date:  2011 Jul-Aug

2.  Undetected cognitive impairment and decision-making capacity in patients receiving hospice care.

Authors:  Cynthia Z Burton; Elizabeth W Twamley; Lana C Lee; Barton W Palmer; Dilip V Jeste; Laura B Dunn; Scott A Irwin
Journal:  Am J Geriatr Psychiatry       Date:  2012-04       Impact factor: 4.105

3.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

4.  Neuropsychological performance within-person variability is associated with reduced treatment consent capacity.

Authors:  Ronald J Gurrera; Michele J Karel; Armin R Azar; Jennifer Moye
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-03       Impact factor: 4.105

5.  Determinants of Capacity to Consent to Research on Alzheimer's disease.

Authors:  Barton W Palmer; Alexandrea L Harmell; Luz L Pinto; Laura B Dunn; Scott Y H Kim; Shahrokh Golshan; Dilip V Jeste
Journal:  Clin Gerontol       Date:  2016-06-07       Impact factor: 2.619

6.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

7.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

8.  Medical decision-making capacity in patients with malignant glioma.

Authors:  Kristen L Triebel; Roy C Martin; Louis B Nabors; Daniel C Marson
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

Review 9.  Assessment of capacity in an aging society.

Authors:  Jennifer Moye; Daniel C Marson; Barry Edelstein
Journal:  Am Psychol       Date:  2013-04

10.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.